Conference Call Schedules, New Diagnostic Tests, Senior-Level Appointments, and Acquisitions - Analyst Notes on Waters, Cepheid, Curtis-Wright, Trimble, and Cognex

NEW YORK, April 22, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Waters Corp. (NYSE: WAT), Cepheid (NASDAQ: CPHD), Curtiss-Wright Corp. (NYSE: CW), Trimble Navigation Limited (NASDAQ: TRMB) Cognex Corporation (NASDAQ: CGNX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1198-100free

--

Waters Corp. Analyst Notes 

On April 8, 2014, Waters Corp. (Waters) announced that it will hold a webcast and conference call discussing its Q1 2014 financial results on April 29, 2014 at 8:30 a.m. ET. The call will be accessible through the Company's website. The replay of the webcast will be available until 12:00 midnight (ET), May 6, 2014. The full analyst notes on Waters Corp. are available to download free of charge at:

http://www.analystsreview.com/1198-WAT-22Apr2014.pdf

--

Cepheid Analyst Notes 

On April 10, 2014, Cepheid announced the launch of Xpert® Norovirus, a qualitative in vitro diagnostic test for rapid identification and differentiation of Noroviruses genogroup I (GI) and genogroup II (GII), which account for the majority of human infections. The test, which runs on Cepheid's GeneXpert® System, will be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. Commenting on the development, Cepheid's Chairman and CEO, John Bishop said, "It is important that patients infected with Norovirus are identified as early as possible. Rapid molecular testing, when combined with prompt infection control measures of infected patients, provides an important new weapon in our battle against healthcare associated infections." The full analyst notes on Cepheid are available to download free of charge at:

http://www.analystsreview.com/1198-CPHD-22Apr2014.pdf

--

Curtiss-Wright Corp. Analyst Notes 

On April 7, 2014, Curtiss-Wright Corp. (Curtiss-Wright) announced that Joanne M. Karimi will succeed Paul J. Ferdenzi as the Company's Vice President, Human Resources, effective immediately. According to the Company, Karimi will report directly to David C. Adams, President and CEO of Curtiss-Wright. Commenting on the development, Adams said, "Joanne brings a wealth of experience in promoting Human Resources best practices to Curtiss-Wright, and is a proven successful executive. She will play a critical role in leading our team towards achieving our strategic growth objectives." Karimi has an extensive background in executive communications, global realignment and restructuring efforts, development and acquisition of talent, and oversight of business strategy and operations. The full analyst notes on Curtiss-Wright Corp. are available to download free of charge at:

http://www.analystsreview.com/1198-CW-22Apr2014.pdf

--

Trimble Navigation Limited Analyst Notes 

On April 2, 2014, Trimble Navigation Limited (Trimble) announced the acquisition of the assets of privately-held GeoDesy and GeoDesy Free Space Optics (FSO) of Budapest, Hungary. According to the Company, GeoDesy, which offers accessories for surveying instruments, lasers, robotics, mapping and Global Satellite Navigation System (GNSS) systems, complements Trimble's current portfolio of products acquired from SECO and Crain Enterprises in 2008. "With the acquisition of GeoDesy, we have strengthened our ability to serve our customers in the European, Middle Eastern and African regions," said Henry Munoz, Business Area Director of Trimble Interconnect Solutions. "Our strategy is to combine our global design capabilities with regional innovation and deliver these solutions through localized manufacturing and distribution centers," Munoz added. The full analyst notes on Trimble Navigation Limited are available to download free of charge at:

http://www.analystsreview.com/1198-TRMB-22Apr2014.pdf

--

Cognex Corporation Analyst Notes 

On April 3, 2014, Cognex Corp. (Cognex) announced that it will release its Q1 2014 financial results on April 30, 2014, after the market closes. Following its earnings release, the Company will host a conference call that same day at 5:00 p.m. ET. The earnings release and conference call are scheduled to coincide with the Company's expected filing of its Form 10-Q for the quarter ending March 30, 2014. The full analyst notes on Cognex Corporation are available to download free of charge at:

http://www.analystsreview.com/1198-CGNX-22Apr2014.pdf

--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES: 

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review